Connecting with the Experts: A COVID-19 Townhall Series

Previous Recordings

2021
COVID-19 Town Hall
December 16, 2021 
View
Timestamps:
• 12:08 What is the latest on the Omicron variant?
• 15:40 How do we protect kids at this moment?
• 18:30 When will we know about boosters for younger children?
• 19:58 How are the clinical trials progressing for vaccines for children under 5?
• 22:18 What do we know about safety of the vaccines for 5-1 1year olds?
• 25:43 If a child is exposed at school, when should we test? When can they go back to school?
• 27:38 How can we approach testing for our staff?
• 31:00 Is MIS-C still occurring?
• 35:58 How do we think about testing for other viral illnesses at this time?
• 37:06 What therapeutics are available for COVID-19 in children?
• 44:00 Should we be doing RSV testing in the outpatient setting?
• 44:50 What can we do to help with vaccine hesitancy?
• 50:20 What have we learned about long COVID?
• 55:22 Should 16- or 17-year-old males get a booster shot?
• 58:05 What gives you optimism going into 2022?
COVID-19 Town Hall
December 2, 2021
View
Experts:
Amy Houtrow, MD, FAAP
Member, AAP Section on Home Care Executive Committee
Chief, Division of Pediatric Rehabilitation Medicine and Vice Chair for Quality and Safety, UPMC Children’s Hospital of Pittsburgh
Ruth Lynfield, MD, FAAP
AAP Red Book Associate Editor
State Epidemiologist and Medical Director at the Minnesota Department of Health
José R. Romero, MD, FAAP, FAAAS, FIDSA, FPIDS
Member, AAP Committee on Infectious Diseases
Immediate Past Chairperson, CDC Advisory Committee on Immunization Practices
Arkansas Secretary of Health; Director, Arkansas Department of Health
Professor of Pediatrics, Pediatric Infectious Diseases, University of Arkansas for Medical Sciences
Timestamps:
• 12:23 What is the Omicron variant?
• 19:09 Why is Omicron a variant of concern and what should we be doing about it? 
• 22:26 How are you talking to families, especially families with children with disabilities, about this new variant?
• 25:12 Is COVID mutating at a rate we would expect for an RNA virus?
• 26:50 How is Omicron impacting children?
• 28:15 When will adolescents be eligible for booster shots?
• 29:48 How are you talking to families about the vaccine?
• 34:18 Can you explain the targets identified by tests and how the variants might affect test accuracy?
• 36:24 If a child is diagnosed with myocarditis after their first vaccine dose, how should we approach a second vaccine dose?
• 39:00 What have we learned about long COVID?
• 41:38 Do vaccines prevent long COVID from breakthrough infections?
• 42:34 Do we know when vaccines will be available for children under 5?
• 44:15 What is the latest on MIS-C?
• 46:55 How is the LEND program preparing people to respond to this pandemic and future public health emergencies?
• 48:52 Are there COVID therapeutics being tested for children?
• 52:35 If I get my first vaccine dose when I am 11 and then have a birthday before my second dose, which vaccine should I receive for my second dose?
• 53:45 Should we consider off label use of the vaccine to provide a booster to a 16-year-old?
• 55:36 What is the difference between third doses and booster shots?
• 56:50 Will COVID become endemic and what will life look like in a post-pandemic world? 
 
COVID-19 Town Hall
November 18, 2021
View Slides
Experts:
James Campbell, MD, MS, FAAP
Member, AAP Committee on Infectious Diseases
Professor, Center for Vaccine Development and Global Health, University of Maryland School of Medicine

Karen Puopolo, MD, PhD, FAAP
Chief, Section on Newborn Medicine, Pennsylvania Hospital
Associate Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine

Robert F. Tamburro, MD, MSc, FAAP
Senior Advisor for Clinical Research, Division of Extramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Timestamps:
• 10:32 Pediatric COVID-19 Research Programs presentation from NICHD 
• 11:38 Caring for Children with COVID Initiative
• 16:48 Safe Return to School Diagnostic Testing study
• 19:46 Recover program
• 21:27 Impact of COVID-19 on neonates
• 27:06 When can we expect vaccines for kids younger than 5?
• 29:16 Are there any updates on non-mRNA vaccines for children? 
• 30:20 How is NICHD working with schools?
• 31:46 What do we know about breastmilk and immunity?
• 33:25 What is the recommended vaccine dosing for kids who receive their first dose at 11 and then turn 12 before the second dose?
• 35:16 What is the difference between the pediatric and adult vaccine vials?
• 36:55 Is the COVID vaccine dosing related to a patient’s weight?
• 37:36 What do we know about vaccines and pregnant women?
• 40:06 What is the latest on COVID and myocarditis?
• 44:24 Who is eligible for a booster shot today?
• 47:04 What is the timing of the additional third (additional) dose for adolescents who are immunocompromised (Correction to response given at 54:06)
• 47:27 What is the optimal timing of vaccination for pregnant people?
• 49:42 How can pediatricians get involved in a study or the work of NICHD?
• 50:40 Clarification around vaccine timing in pregnancy
• 51:25 How soon after COVID illness can I be vaccinated?
• 54:06 Correct timing of third vaccine dose for adolescents who are immunocompromised
• 54:40 If one has a breakthrough infection while partially vaccinated, what does their vaccination schedule look like?
• 55:33 What have we learned during the pandemic that should be applied for the future of research and medical care?
 
COVID-19 Updates
November 4, 2021
View
Experts:
Bonnie Maldonado, MD, FAAP 
Chairperson, AAP Committee on Infectious Diseases 
Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development, Stanford University School of Medicine 
Sean O’Leary, MD, MPH, FAAP
Vice Chairperson, AAP Committee on Infectious Diseases 
Professor, Pediatrics, Sections of Pediatric Infectious Diseases and General Academic Pediatrics,
University of Colorado Anschutz Medical Campus, Children’s Hospital Colorado
Timestamps:
• 12:18 What happened at the ACIP meeting and what was the result?
• 14:02 How did ACIP look at the benefits of the vaccine for this age group?
• 18:22 Why is the dose different for ages 5-11?
• 19:32 What do we do if a child turns 12 between their doses of the vaccine?
• 21:32 Are there any contraindications to this vaccine?
• 22:24 Should my child get the vaccine if they have had COVID?
• 24:44 What do we know about myocarditis after vaccination for this age group?
• 28:10 How should we think about third doses and boosters for all age groups?
• 33:04 Are we still seeing MIS-C? How should we think about vaccines for children who have had MIS-C?
• 35:00 What do we know about immunity to COVID-19?
• 38:03 What do we know about vaccines for children younger than 5?
• 40:10 If I have a child who is nearly 12, should we wait to get them vaccinated until they turn 12 so they can get the larger vaccine dose?
• 42:40 How can we respond to concerns about fertility and the COVID vaccines?
• 45:28 How do you respond to families that believe children don’t become as sick with COVID-19 and vaccination is unnecessary right now?
• 48:28 What is the best way to address a family’s questions and concerns about the vaccine?
• 52:34 What is V-safe and why is it important?
• 58:22 Review of plan if receive first dose at 11 years old and second at 12 years old
• 59:03 What medical innovations or lessons will we carry forward from the pandemic?
COVID-19 Town Hall
October 28, 2021
View
Experts:
Shaquita Bell, MD, FAAP
Immediate Past Chair, AAP Committee on Native American Child Health
Seattle Children’s and University of Washington
James Campbell, MD, MS, FAAP
Member, AAP Committee on Infectious Diseases
University of Maryland Hospital for Children
Lisa Costello, MD, MPH, FAAP
President, West Virginia Chapter AAP
Assistant Professor General Pediatrics, West Virginia University
Timestamps:
• 11:58 What is the latest on vaccines for children ages 5-11?
• 15:23 What was the incidence of myocarditis in the trials with 5–11-year-olds?
• 19:04 How are states preparing for the vaccine rollout? 
• 26:00 What is the role of community clinics in vaccine rollout?
• 33:08 How is vaccine storage different for these vaccines?
• 36:40 How was the vaccine dosage determined?
• 38:10 What are the common reasons families are hesitant about the vaccine and how should we respond?
• 44:33 How are you talking about the possible long-term effects of the vaccine?
• 47:43 How do you answer concerns about fertility related to the vaccines?
• 52:58 If my child had COVID, do they need the vaccine?
• 54:14 How do you continue to support your staff and colleagues?
 
COVID-19 Town Hall
October 14, 2021
View
Experts:
Benson Hsu, MD, MBA, FAAP, FCCM
Chair-Elect, AAP Section on Critical Care
Professor of Pediatrics, University of South Dakota Sanford School of Medicine
Chief Scientific Officer, Preparedness Treatment and Equity Coalition

Kimberly Montez, MD, MPH, FAAP
Vice Chair, AAP Council on Community Pediatrics
Assistant Professor of Pediatrics; Associate Program Director, Pediatrics Residency; and Associate Director of Integrating Special Populations, Maya Angelou Center for Health Equity at Wake Forest School of Medicine

José R. Romero, MD, FAAP, FAAAS, FIDSA, FPIDS
Member, AAP Committee on Infectious Diseases
Immediate Past Chairperson, CDC Advisory Committee on Immunization Practices
Arkansas Secretary of Health; Director, Arkansas Department of Health
Professor of Pediatrics, Pediatric Infectious Diseases, University of Arkansas for Medical Sciences
Timestamps:
• 10:38 What is the latest on vaccines for children ages 5-11?
• 11:36 What is the anticipated timeline for vaccines for children ages 5-11? 
• 12:03 How are you talking to families and communities about the vaccine? 
• 13:38 How do you combat misinformation around COVID-19 vaccines? 
• 15:55 Where will vaccines be available for children ages 5-11? 
• 17:47 How should pediatricians be thinking about access to these vaccines? 
• 20:58 Do you anticipate a shortage of vaccines? 
• 22:03 Will there be vial or dose differences for the vaccines for children ages 5-11? 
• 22:53 What are best practices for one-to-one conversations with families about the vaccine? 
• 26:54 Why shouldn’t we just draw up smaller doses of vaccine for children from the adult vaccine vials? 
• 28:55 What do we know about the safety profile of the vaccine? 
• 30:26 What are hospitals seeing in children during the COVID surges? 
• 31: 20 What are the treatment recommendations for hospitalized children? 
• 34:15 What is the role of monoclonal antibodies for children? 
• 35:18 How are social drivers impacting families during the pandemic? 
• 38:08 Are you administering vaccines in the inpatient setting? 
• 39:58 What do we know about long COVID or the post-acute sequalae of COVID-19? 
• 43:14 What are other pressing child health issues we should be thinking about in our communities? 
• 46:53 How are children being affected by the loss of or separation from parents or family members? 
• 49:09 When and how to test for flu, COVID, or other viruses? 
• 52:02 Any predictions for the future of COVID variants? 
• 54:10 How can we support the socio-emotional needs of our patients and families? 
• 56:50 How can we support our colleagues in healthcare? 
• 59:18 When can we tell our patients and families that they will be able to go back to “normal”? 
 
COVID-19 Town Hall
September 30, 2021
View
Experts:
Dennis Z Kuo, MD, MHS, FAAP
Immediate Past Chairperson, AAP Council on Children With Disabilities
Associate Professor of Pediatrics and Division Chief of General Pediatrics at the Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Bonnie Maldonado, MD, FAAP
Chairperson, AAP Committee on Infectious Diseases
Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development, Stanford University School of Medicine
Kate Remick, MD, FAAP, FACEP, FAEMS
Associate Professor of Pediatrics at Dell Medical School at the University of Texas at Austin
Co-Director, National EMS for Children Innovation and Improvement Center; Medical Director, San Marcos/Hays County EMS System; Co-Director, National Pediatric Readiness Project (NPRP)
Timestamps:
• 10:46 What is the latest on vaccines for children ages 5-11?
• 12:34 How can we talk about the COVID-19 vaccines with families of children with special healthcare needs or medical complexity?
• 14:36 What is a surge and what is being seen with them?
• 15:50 What advice do you have for general pediatricians in a surge?
• 17:03 What is the status of vaccine data submission to the FDA?
• 18:54 With increased pediatric COVID cases, how can we respond to vaccine hesitancy?
• 24:55 Are there any updates on the risk of myocarditis after vaccination?
• 26:48 Is there a correlation between antibody levels and myocarditis?
• 28:18 Most children do not live close to children’s hospitals and will visit community emergency departments. What kind of education and coordination is taking place with those community hospitals?
• 30:15 How can we work with the community and schools on strategies to mitigate the risk of COVID-19 transmission?
• 32:48 What kind of masks should children wear?
• 34:14 What is the current guidance about COVID testing?
• 40:26 What is the frequency of MIS-C cases and how can we identify it?
• 44:06 If a child has had COVID, when should they get the vaccine?
• 46:40 What have we learned about long COVID?
• 50:16 How should we address writing mask exemptions, especially for children with special healthcare needs?
• 52:51 What will be the long-term effects of the pandemic on children and pediatric health systems? 
How are the Children?
September 9, 2021
View
Experts:
Elizabeth Alderman, MD, FAAP
Chair, Committee on Adolescence
Chief, Division of Adolescent Medicine at the Children’s Hospital at Montefiore and founder of the Montefiore Adolescent Primary Care Initiative
James Campbell, MD, MS, FAAP
Member, Committee on Infectious Diseases
University of Maryland Hospital for Children
Dave Mathison, MD, MBA, FAAP
Vice Chair, Section on Urgent Care Medicine
Sr Vice President of Clinical Operations at PM Pediatrics
Timestamps:
• 13:05 What is the latest on vaccines for children ages 5-11?
• 15:08 Is there an update on the Moderna vaccine for 12–18-year-olds?
• 16:24 How should we be taking to teens and families about the vaccines?
• 18:24 What COVID tests should be used?
• 22:45 What is the guidance about the timing of testing?
• 25:45 What is the role of antibody testing? 
• 28:22 Discussion of antibody testing and boosters
• 31:33 How do you decide what viruses to test for?
• 33:20 How are kids doing as they go back to school? How can we help reduce their stress?
• 35:25 What do you do when schools are struggling to stay open? How can we support kids and families and their mental health? 
• 37:50 What are we seeing in teens with eating disorders, obesity, and mental health concerns during the pandemic?
• 42:28 How do you navigate when a teen would like to be vaccinated and their parents are hesitant?
• 45:00 How do you handle testing when day cares are specifically requesting RSV or other testing?
• 47:10 What happens to people who get COVID more than once and what do we know about long COVID?
• 50:45 Who are monoclonal antibodies recommended for?
• 56:18 How can we maintain our resilience and continue to move forward?
 
COVID-19 – What's the Latest?
September 2, 2021
View
Experts:
Sara Bode, MD, FAAP
Chairperson-elect, AAP Council on School Health
Medical Director, Nationwide Children's Hospital's Care Connection School-Based Health and Mobile Clinics
Bonnie Maldonado, MD, FAAP
Chairperson, AAP Committee on Infectious Diseases and Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development and Diversity at Stanford University School of Medicine
Joelle Simpson, MD, MPH, FAAP
Executive Committee Member, AAP Council on Children and Disasters, Chief of Emergency Medicine and medical Director for Emergency Preparedness, Children’s National Hospital
Timestamps:
• 12:52 Is the Delta variant more severe?
• 13:53 What is happening in emergency departments right now?
• 15:33 How should we think about the issue of co-infection?
• 16:23 Has anything changed since kids have gone back to school?
• 18:18 As pediatricians, what should we be doing in the community?
• 22:12 Do masks work and what kind should we recommend?
• 25:12 How are schools handling unmasked lunchtime?
• 27:52 When do you test and what do you test for in a clinical environment, given the number of viruses circulating?
• 35:23 What is the role of home COVID-19 tests?
• 37:20 Is there a case where we would need to support children not being physically in school?
• 40:35 When can we expect vaccines for 5–11-year-olds and then younger children?
• 43:48 What are the updates on booster shots?
• 47:50 What role can hospitals play in providing vaccines?
• 49:10 What should we be saying to parents about vaccines?
• 51:08 When should monoclonal antibodies be used?
• 54:28 Are monoclonal antibodies easily available?
• 55:50 How do we continue to support one another, our patients, families, and communities?
 
COVID-19 Hot Topics
August 19, 2021 
View
Experts:
Sara Bode, MD, FAAP
Chairperson-elect, AAP Council on School Health
Medical Director, Nationwide Children's Hospital's Care Connection School-Based Health and Mobile Clinics
David W. Kimberlin, MD, FAAP
Editor, AAP Red Book
Sergio Stagno, MD Endowed Chair in Infectious Diseases
Co-Director of the Division of Pediatric Infectious Diseases; and Vice Chair for Clinical and Translational Research at University of Alabama at Birmingham
Bonnie Maldonado, MD, FAAP 
Chairperson, AAP Committee on Infectious Diseases 
Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development, Stanford University School of Medicine 
Timestamps:
• 3:34 Review of national pediatric COVID-19 case data 
• 5:09 Pediatric COVID-19 hospitalizations 
• 6:02 Review of current pediatric COVID-19 vaccination data 
• 11:10 What do we know about the Delta variant? 
• 15:32 Can kids safely go to school? 
• 17:30 How do we work with families to promote vaccines and other mitigation strategies? 
• 19:20 Is there a situation where pediatricians would recommend closing schools? 
• 21:37 What type of mask should kids wear to school? 
• 24:03 Are there any specific mask recommendations for kids younger than 5? 
• 25:25 What are the current recommendations for the types and timing of COVID-19 testing? 
• 29:35 How can we be thinking about home testing or testing asymptomatic children? 
• What are the current updates on COVID-19 vaccines? (3^rd additional dose – 33:12, booster recommendation – 34:22, and vaccine approval in younger children – 36:34)
• 40:15 Why is RSV circulating right now? 
• 45:00 How do pediatricians support families, teachers, and schools and help them think about risk? 
• 47:20 Should a child who is not old enough to be vaccinated be visiting their grandparents? 
• 49:55 Are MIS-C cases increasing? 
• 51:05 What are the risk factors for severe COVID-19 or MIS-C? 
• 56:00 Messages of hope for our colleagues and children
 
COVID-19 Town Hall Featuring the 2021 President-Elect Candidates
July 22, 2021
View
 
Acute and Long-Term Impact of SARS-CoV-2
July 8, 2021
View Slides
Experts:
Stuart Berger, MD, FAAP
Chairperson, AAP Section on Cardiology and Cardiac Surgery
Division Head, Cardiology, Lurie Children’s Hospital
Associate Chair of Clinical Affairs and Chief of Cardiology, Department of Pediatrics; Professor of Pediatrics (Cardiology and Critical Care) and Medicine (Cardiology), Northwestern University Feinberg School of Medicine

Sarah Risen, MD, FAAP
Faculty, Department of Pediatric Neurology and Meyer Center for Developmental Pediatrics, Texas Children’s Hospital; Assistant Professor, Baylor College of Medicine

Robert F. Tamburro, MD, MSc, FAAP
Senior Advisor for Clinical Research, Division of Extramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Timestamps:
• 8:32 Presentation by Dr Tamburro on current pediatric COVID-19-related research supported by the NIH
• 23:55 Poll: Have you provided care to any patients with long COVID?
• 24:28 Poll results
• 24:44 What are the symptoms of long COVID in pediatric patients?
• 26:43 What are pediatric cardiologists seeing in children with COVID-19 and long COVID?
• 28:26 What are the similarities between POTS (postural orthostatic tachycardia syndrome) and long COVID?
• 30:15 Are there predisposing factors for developing pediatric long COVID?
• 33:04 Is research being done to investigate mitochondrial dysfunction in children who have had COVID-19?
• 35:53 What physiologic mechanisms cause long COVID-19 in children?
• 37:29 What are the recommended treatments for children with long COVID?
• 39:10 How can a pediatrician determine when to refer a patient with long COVID to other specialists?
• 43:15 Do vaccines play a role in preventing or treating long COVID?
• 45:08 How should we be thinking about return to sports and activities?
• 47:45 How can we support children with long COVID as they head into the school year?
• 49:33 How are families being involved in COVID-19 research?
• 52:44 What work is being done on vaccine access and addressing vaccine hesitancy?
• 56:52 What advice would you give to families right now?
 
COVID-19 Updates
June 24, 2021
View
Experts:  
Stuart Berger, MD, FAAP
Chairperson, AAP Section on Cardiology and Cardiac Surgery
Division Head, Cardiology, Lurie Children’s Hospital
Associate Chair of Clinical Affairs and Chief of Cardiology, Department of Pediatrics; Professor of Pediatrics (Cardiology and Critical Care) and Medicine (Cardiology), Northwestern University Feinberg School of Medicine

Bonnie Maldonado, MD, FAAP 
Chairperson, AAP Committee on Infectious Diseases 
Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development, Stanford University School of Medicine 

Sean O’Leary, MD, MPH, FAAP
Vice Chairperson, AAP Committee on Infectious Diseases 
Professor, Pediatrics, Sections of Pediatric Infectious Diseases and General Academic Pediatrics, University of Colorado Anschutz Medical Campus, Children’s Hospital Colorado
Timestamps:
• 8:38 Summary of this week’s ACIP meeting and discussion about pediatric vaccination and myocarditis
• 12:42 What are the clinical manifestations of post-vaccination myocarditis?
• 14:48 If a patient presents to my general pediatric clinic with symptoms of myocarditis, what should I do?
• 15:48 How do we discuss the myocarditis risk with families?
• 21:30 What should we know about the Delta variant and children?
• 27:07 Should a patient with a personal or family history of congenital heart disease get a COVID-19 vaccine?
• 28:02 Have the recommendations for return to sports or activities changed for children with post-vaccine myocarditis?
• 29:45 How do we think about antibody tests and the need for vaccines?
• 35:00 Can we predict who is at greater risk for developing post-vaccine myocarditis? Is the workup different if a patient has received a COVID-19 vaccine recently?
• 36:28 Are there any updates on the potential need for booster doses of COVID-19 vaccines?
• 39:31 How can we address the myth that mRNA vaccines are related to infertility?
• 42:02 Is there any benefit to recommending ibuprofen after COVID-19 vaccination?
• 43:48 What do we know about the mechanism that is causing myocarditis?
• 45:08 How can we protect children who are under 12 and cannot receive the vaccine?
• 48:14 When do we anticipate that vaccines will be available for children under 12?
• 50:03 Are there any updates on possible antiviral medications?
• 53:34 Is there evidence that myocarditis risk varies by vaccine manufacturer?
• 54:40What advice should we be giving to parents and families at this moment in time?
 
A Conversation and Call to Action: A COVID-19 Vaccine Town Hall with U.S. Surgeon General Dr. Vivek Murthy
June 10, 2021
View
 
COVID-19 Vaccine Updates
May 13, 2021
View
Experts:
Amanda Cohn, MD, FAAP 
Executive Secretary, Advisory Committee on Immunization Practices 
Chief Medical Officer, National Center for Immunization and Respiratory Diseases , Centers for Disease Control and Prevention 
Bonnie Maldonado, MD, FAAP
Chairperson, AAP Committee on Infectious Diseases
Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development and Diversity at Stanford University School of Medicine
Timestamps:
• 1:18 Review of current pediatric COVID-19 case data
• 2:13 Review of new AAP Policy, COVID-19 Vaccines in Children and Adolescents
• 6:28 Overview of the week’s vaccine-related events
• 17:26 Are there contraindications to COVID-19 vaccine in 12–15-year-olds?
• 18:26 Can a patient who has had MIS-C received the COVID-19 vaccine? If so, when?
• 22:48 Do children who have tested positive for COVID-19 need to wait 90 days before receiving a COVID-19 vaccine?
• 28:20 Is there any evidence that COVID-19 vaccines can impact future fertility?
• 36:12 Can you explain what the new mask guidance means?
• 42:14 How long will immunity from COVID-19 vaccines will last?
• 50:40 When can we anticipate an EUA for Moderna for children as young as 12? What about COVID-19 vaccines for children younger than 12?
• 53:49 When can we anticipate full approval for the Pfizer COVID-19 vaccine?
• 54:38 Can we pursue vaccinating young children and vaccinating the rest of the world simultaneously?
• 56:44 How can we get parents just as excited about getting their children vaccinated as we are?
Ask the Red Book About COVID-19  - Part 3
April 22, 2021
View
Experts:
David W. Kimberlin, MD, FAAP
Editor, AAP Red Book
Sergio Stagno, MD. Endowed Chair in Infectious Diseases; Co-Director of the Division of Pediatric Infectious Diseases; and Vice Chair for Clinical and Translational Research at University of Alabama at Birmingham

Bonnie Maldonado, MD, FAAP 
Chairperson, AAP Committee on Infectious Diseases 
Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development, Stanford University School of Medicine 

Sean O’Leary, MD, MPH, FAAP
Vice Chairperson, AAP Committee on Infectious Diseases 
Professor, Pediatrics, Sections of Pediatric Infectious Diseases and General Academic Pediatrics,
University of Colorado Anschutz Medical Campus, Children’s Hospital Colorado
Timestamps:
• 3:09 Review of current pediatric COVID-19 case data
• 4:38 COVID-19 vaccine attendee poll
• 6:10 2021 Red Book updates and release date
• 9:16 When will the COVID-19 vaccine be ready for kids?
• 10:48 What is happening with the Johnson & Johnson vaccine?
• 15:15 What is the status of the COVID-19 variants?
• 20:20 What are the differences between variants of interest, variants of concern, and variants of consequence? 
• 23:03 Should we anticipate a need for a COVID-19 vaccine booster in the future? 
• 25:40 What do we know about transmission of COVID-19 antibodies in breast milk? 
• 29:28 How can we advise vaccinated parents about travel and the need to wear masks? 
• 35:44 When can we safely gather with one another indoors, without masks? 
• 37:40 How do we advise people who have had one dose of any of the vaccines? Should they or can they get a second dose from another manufacturer? 
• 39:25 What are the contraindications for COVID-19 vaccines in eligible children? 
• 42:56 What is the advice about coadministration of vaccines in order to help children catch up on vaccines? 
• 48:18 How can pediatricians be addressing vaccine hesitancy? 
• 52:06 How accurate are our existing COVID-19 tests, given the emergence of variants? 
• 53:30 Are there updates about COVID-19 testing and schools? 
• 55:16 How can we working with communities to overcome vaccination disparities? 
 
Ask the Red Book About COVID-19 – Part 2
April 8, 2021
View
Timestamps:
• 00:24 “Call You Pediatrician” PSA
• 2:36 Review of current pediatric COVID-19 case data
• 7:52 Overview of COVID-19 vaccines for children in the United States
• 13:42 What is the time frame for vaccine availability for children?
• 17:57 What is the latest on COVID-19 variants and will the vaccines work against them?
• 25:02 How can we translate the promising data about the vaccines to promote vaccine confidence?
• 28:29 Have COVID-19 testing recommendations changed because of COVID-19 variants?
• 31:01 What do we know about perinatal transmission of COVID-19?
• 33:04 What do we know today about the safety of vaccines for pregnant and breastfeeding women?
• 35:39 Do the COVID-19 vaccines have any impact on fertility?
• 39:00 Can kids go to camp safely this year?
• 41:25 Who needs to quarantine? When? Why?
• 45:15 What are the common vaccine side effects, and do we need to worry about MIS-C in vaccinated adolescents?
• 48:42 Will we need booster shots for COVID-19 in the future?
• 52:22 Will we be able to administer other vaccines with COVID-19 vaccines?
• 55:46 What do you wish you had known about COVID-19 one year ago?
COVID-19 Pediatric Clinical Updates
March 18, 2021
View
Experts:
Ed Conway, Jr, MD, MS, FAAP, FCCM
Professor of Pediatrics, Division Chief Pediatric Critical Care, Chairman Department of Pediatrics Jacobi Medical Center

Sandy Hong, MD, FAAP
Chairperson, AAP Section on Rheumatology
Clinical Professor of Pediatrics, Rheumatology, Allergy, and Immunology, University of Iowa Carver College of Medicine

Bonnie Maldonado, MD, FAAP 
Chairperson, AAP Committee on Infectious Diseases 
Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development, Stanford University School of Medicine 

Peter C. Rowe, MD, FAAP
Director, Children’s Center Chronic Fatigue Clinic, Johns Hopkins Hospital
Professor of Pediatrics, Johns Hopkins University School of Medicine
Timestamps:
• 3:02 Review of current pediatric COVID-19 case data
• 8:48 What do you know today that you wish you had known a year ago?
• 14:44 When do we start to think about MIS-C as a diagnosis for a patient?
• 16:22 How do we use inflammatory markers to differentiate MIS-C from other inflammatory conditions or sepsis?
• 18:29 When will we have COVID-19 vaccines for children?
• 20:30 What are the criteria for long COVID-19?
• 22:44 How can we treat long COVID-19? Will the COVID-19 vaccine help?
• 25:53 Can you explain the peripheral vasculitis found in some pediatric patients with COVID-19?
• 27:16 How do you tell the difference between “COVID toes” and frostbite?
• 27:56 How should MIS-C be treated?
• 34:25 How worried should we be about variants and how will variants impact vaccine trials?
• 40:08 How can we approach staff refusing COVID-19 vaccination?
• 44:26 When should a general pediatrician think about long COVID and what support do patients with long COVID need?
• 46:55 How can teams respond to the socioemotional needs of the families of children with MIS-C?
• 50:42 How do we support students, especially children with long COVID, for the long term?
• 54:37 What piece of advice would you give to your colleagues for the year ahead?
Schools, Sports, and Socioemotional Health
March 4, 2021
View
Experts:

Susannah “Suz” Briskin, MD, FAAP
Executive Committee Member, AAP Council on Sports Medicine and Fitness; Associate Professor of Pediatrics in the Division of Sports Medicine at Rainbow Babies and Children’s Hospital; Head Team Physician for Hathaway Brown School and Assistant Team Physician for Case Western Reserve University.

Danielle Dooley, MD, MPhil, FAAP
Member, AAP Council on School Health; Medical Director, Community Affairs and Population Health, Child Health Advocacy Institute, Children’s National Medical Center; Assistant Professor of Pediatrics at George Washington University

Carol Weitzman, MD, FAAP
Immediate Past Chair, AAP Section on Developmental and Behavioral Pediatrics; Co-Director Autism Spectrum Center, Division of Developmental Medicine at Boston Children's Hospital; Professor of Pediatrics at Yale
 
Timestamps:
• 5:28 Review of current pediatric COVID-19 case data
• 8:56 How are you talking to your patients and families to prepare them to get back to school and sports?
• 14:32 Can you clarify the recommendations around physical distancing in schools? 
• 17:09 Can you clarify the recommendations for evaluation by the pediatrician or pediatric cardiologist for children returning to sports? 
• 19:38 What tips do you have for children and families that are anxious about returning to the classroom or are struggling with remote learning? 
• 25:08 Can you talk about why the AAP guidance about cardiology and return to sports seems more conservative than the guidance of other organizations?
• 27:37 How do we work with families to support physical activity?
• 29:06 How can we think about upcoming standardized tests and possible learning loss for students? 
• 34:47 How can pediatricians support children and communities to catch-up academically?
• 37:27 How can we promote pediatric socioemotional well -being though physical activity? 
• 40:06 How can we help children gradually transition to returning to school?
• 41:52 What conversations can we have with families to help them transition to a “new normal”?
• 48:27 How can we keep kids engaged and learning outside of school?
• 51:38 What have you had to do differently in your practice during the pandemic that you will continue to do in the future? 
• 56:25 What gives you optimism for the next six months? 
 
What’s Happening to the Children?
February 18, 2021 at 7 pm CT
View
Experts:
Ihuoma Eneli MD, MS, FAAP
Professor of Pediatrics, The Ohio State University
Director, Center for Healthy Weight and Nutrition
Nationwide Childrens Hospital
Kimberly Montez, MD, MPH, FAAP
Assistant Professor of Pediatrics, Assistant Program Director, Pediatrics Residency, Associate Director of Integrating Special Populations, Maya Angelou Center for Health Equity at Wake Forest School of Medicine;
Vice Chair, Council on Community Pediatrics, American Academy of Pediatrics
Sonja O’Leary, MD, FAAP
Chairperson-elect, AAP Council on School Health; Assistant Professor, Pediatrics University of Colorado School of Medicine; Medical Director, Denver Health, School-Based Health Centers.
Timestamps:
• 3:25 Review of current pediatric COVID-19 case data
• 7:27 How is the pandemic currently impacting children in your community?
• 12:28 What are the social drivers of health and how are they different from the social determinants? 
• 13:49 How can schools address social drivers? 
• 15:35 How can pediatricians best address food insecurity and what are best practices for screening for it? 
• 17:55 How can pediatricians address the effects of racism on children and families? 
• 21:24 How can schools help address disparities in educational attainment? 
• 23:00 How do you screen for and discuss racism with families? 
• 25:56 What are some specific screening tools for social drivers? 
• 28:40 How do we engage our teams to think about social drivers? 
• 30:30 How can we support adolescent social development when they are not attending school in-person? 
• 32:25 How do we best screen and assess children for mental health concerns? 
• 34:19 How can schools effectively serve children and youth with special healthcare needs at this time? 
• 35:44 How do we best support families dealing with obesity? 
• 41:22 How do we support adolescents who may have entered the workforce or are caring for siblings? 
• 43:32 What are other community resources, besides schools, that pediatricians can partner with? 
• 46:42 How are we reaching children and families facing homelessness? 
• 48:12 How can schools address chronic absenteeism? 
• 50:52 When children are not coming to school or clinic, how can we reach them? 
• 54:04 How should the pandemic change how pediatricians interact with communities? 
 
Addressing Uncertainty: Looking Ahead to Year 2
February 4, 2021 at 7 pm CT
View
Experts:
Bonnie Maldonado, MD, FAAP
Chairperson, AAP Committee on Infectious Diseases
Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development at Stanford University School of Medicine

James Duffee, MD, MPH, FAAP
Clinical Associate Professor, Pediatrics; Clinical Assistant Professor, Psychiatry
Boonshoft School of Medicine, Wright State University
Matthew Molloy, MD, MPH, FAAP
Clinical Fellow, Division of Hospital Medicine at Cincinnati Children’s Hospital
Timestamps:
• 3:27 Review of current pediatric COVID-19 case data
• 8:58 What were you predicting for the future when you first heard about COVID in February 2020?
• 14:44 What does normal look like moving forward? When can we say, “this is done?”
• 25:55 How should we be thinking about the COVID variants?
• 31:25 Are the virus mutations leading to more deadly variants?
• 32:21 How do we talk to people about how the virus is impacting children?
• 37:37 How will the pandemic transform hospital medicine in the future?
• 41:22 How can leaders support their teams at this time?
• 46:00 What kind of structures can we put in place now to support the profession in the future?
• 51:24 How can early career physicians care for themselves?
• 53:56 When will COVID vaccine be approved for children?
• 55:35 What is something we should be looking forward to in 2021?
 
“Ask the Red Book” About COVID-19
January 21, 2021 at 7 pm CT
View
Experts:
David W. Kimberlin, MD, FAAP
Editor, AAP Red Book
Sergio Stagno, MD. Endowed Chair in Infectious Diseases; Co-Director of the Division of Pediatric Infectious Diseases; and Vice Chair for Clinical and Translational Research at University of Alabama at Birmingham

Bonnie Maldonado, MD, FAAP
Chairperson, AAP Committee on Infectious Diseases
Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development at Stanford University School of Medicine
Timestamps:
• 2:45 Review of current pediatric COVID-19 case data
• 6:06 What can you tell us about the new COVID-19 variant(s)?
• 8:53 Why are the variants more contagious?
• 10:29 What should pediatricians be telling parents who are concerned about the variants? 
• 12:51 When are kids going to be able to receive a COVID-19 vaccine?
• 16:55 How quickly can we vaccinate children with medical complexity who are at high risk?
• 19:02 What do we know about the vaccine and pregnant or breastfeeding mothers?
• 23:00 Is there evidence that the vaccine could trigger MIS-C?
• 25:13 What types of issues being discussed by the Advisory Committee on Immunization Practices (ACIP)?
• 28:46 What is the optimal way to use rapid COVID-19 tests?
• 36:18 How can pediatricians be partnering with schools?
• 41:27 What therapeutics are available or recommended for children?
• 46:09 What do we know about transmission from vaccinated health care workers?
• 47:07 Are there new quarantine recommendations for vaccinated health care workers?
• 49:19 Should vaccinated health care workers wear full PPE for aerosol-generating procedures?
• 49:42 If I had COVID-19 last year, what is my risk of becoming ill with a new variant?
• 52:03 How can we best support our infectious disease experts?
• 55:50 Updates about the newest edition of the Red Book
COVID-19 and Safe Return to Schools Q&A
January 7, 2021
View
Experts:
Bonnie Maldonado, MD, FAAP
Chairperson, AAP Committee on Infectious Diseases and Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development and Diversity at Stanford University School of Medicine.
Arwa Nasir, MBBS, MSc, MPH, FAAP
Member, Committee on Psychosocial Aspects of Child & Family Health; Chief, Division of General Pediatrics,  Associate Professor, Division of General Pediatrics, University of Nebraska Medical Center.
Sonja O’Leary, MD, FAAP
Chairperson-elect, AAP Council on School Health; Assistant Professor, Pediatrics University of Colorado School of Medicine; Medical Director, Denver Health, School-Based Health Centers.
Timestamps:
• 4:36 Review of current pediatric COVID-19 case data
• 8:48 What are the urgent issues requiring collaboration between pediatricians, children, families, and schools?
• 13:45 Is periodic COVID-19 surveillance testing for children and school staff a good idea?
• 17:41 How can we help children cope with anxiety about returning to school and/or learning at home?
• 20:26 How might the new SARS-CoV-2 variant impact return to schools?
• 24:42 How do we partner with the communities that are being disproportionately affected by COVID-19?
• 29:22 How do we screen for mental health and mitigate the effects of ongoing stress for our patients, families, and communities?
• 33:34 What are the most up to date recommendations around quarantine and return to school?
• 30:00 Are there age group considerations for return-to-school recommendations?
• 42:16 How can we best support children with ADD/ADHD in a virtual learning environment?
• 44:44 How should we be talking about the COVID-19 vaccines with our families right now?
• 51:02 What is the AAP recommendation for physical distancing in schools?
• 54:22 What are the recommendations around physical education in schools?
• 55:44 What is one piece of advice you would give to parents as children enter the last half of the school year?
2020
COVID-19 Vaccine Q&A
December 17, 2020
View
Experts:
James Campbell, MD, MS, FAAP
Member, AAP Committee on Infectious Diseases
University of Maryland Hospital for Children
Lisa Costello, MD, MPH, FAAP
Assistant Professor General Pediatrics, West Virginia University
President, West Virginia Chapter AAP
Timestamps:
• 2:34 Review of current pediatric COVID-19 case data
• 7:45 What has been the application and review process for the approved vaccines?
• 11:15 How are state vaccine distribution plans being implemented?
• 11:15 What are the similarities and differences between the Pfizer and Moderna vaccines?
• 20:07 What is the difference between the ages of the participants enrolled in the clinical trials for each vaccine?
• 21:50 How can we translate the science behind the safety and efficacy of these vaccines into communication to our communities?
• 28:42 Are there any contraindications to vaccination and how will safety be monitored going forward?
• 32:38 Is polyethylene glycol a concern for causing allergic reactions?
• 33:28 Will the VAERS system be used to monitor adverse events? What other technology is available to document side effects?
• 36:33 What are some ideas to help people track which type of vaccine they received and when they are due for their second dose?
• 40:40 How exact must the timing of the second dose be?
• 43:12 How long does the immune response to the vaccine last?
• 45:15 How should people who have been recently infected with COVID-19, or are potentially asymptomatic, approach receiving the vaccine?
• 49:30 Can we stop wearing masks after getting the vaccine?
• 52:07 Does the vaccine prevent transmission?
• 53:40 Are there concerns for MIS-C when children begin receiving the vaccine?
• 56:30 What is the role of pediatricians right now?
COVID-19 Vaccine
December 3, 2020
View
Experts:
Amanda Cohn, MD, FAAP 
Executive Secretary, Advisory Committee on Immunization Practices 
Chief Medical Officer, National Center for Immunization and Respiratory Diseases and COVID-19 Vaccine Task Force , Centers for Disease Control and Prevention 
James Campbell, MD, MS, FAAP 
Member, AAP Committee on Infectious Diseases 
University of Maryland Hospital for Children
Timestamps:
• 1:14 Overview of COVID-19 Data in Children
• 5:04 Dr Amanda Cohn presentation "COVID-19 Vaccine Implementation"
• 5:37 Explaining mRNA COVID-19 Vaccines
• 6:46 Overview of COVID-19 Vaccine Distribution
• 9:08 COVID-19 Vaccine and Children
• 10:43 Vaccinating Pregnant Women
• 12:11 ACIP Allocation of COVID-19 Vaccine
• 15:54 Distribution of COVID-19 Vaccine
• 17:09 Pfizer and Moderna COVID-19 Vaccine Storage and Handling Requirements
• 18:41 Reactions to mRNA Vaccines
• 19:55 Proposed Clinical Considerations for Vaccines
• 21:44 Jurisdictional Vaccine Implementation
• 22:33 COVID-19 Vaccine Provider Recruitment
• 23:30 COVID-19 Vaccine Safety Strategy
• 25:52 Vaccine Confidence
• 28:07 Actions that You Can Take Now
• 30:45 Dr Jim Campbell Presentation
• 32:15 Overview of Vaccine Products
• 41:00 Are Children Involved in COVID-19 Vaccine Research?
• 44:10 More Data about Pfizer/BioNTech and Moderna Vaccine Results
• 50:05 What is the definition of a health care worker? How do we address vaccine confidence and reach communities that are disproportionately affected by COVID-19?
• 53:42 How is vaccine efficacy determined in vaccine trials?
• 56:05 What is the one message we should take back to families and co-workers about the COVID-19 vaccine?
Physician Resilience in the Time of COVID-19
November 19, 2020
View
Experts:
Melanie Brown, MD, MSE, FAAP 
Chairperson, AAP Section on Integrative Medicine 
Member of the AAP Wellness Advisory Group 
Medical Director Harriet Lane Compassionate Care Team, Johns Hopkins School of Medicine 
 
Riva Kamat, MD, FAAP 
Vice Chair, AAP Section on Hospital medicine Provider Wellness Subcommittee
Pediatric Hospitalist, Inova Fairfax Hospital for Children 
 
Christine Moutier, MD 
Chief Medical Officer, American Foundation for Suicide Prevention 
 
Robert “Bo” Riewerts, MD, FAAP 
Regional Chief of Pediatrics, Southern California Permanente Medical Group 
Clinical Lead for Childhood Total Health – KP Care Management Institute 
 
Timestamps:
• 3:33 Review of current pediatric COVID-19 case data
• 8:18 What is resilience and how can we build it?
• 15:40 How can pediatricians prepare themselves to get through the coming months? 
• 18:16 How do we support our colleagues?
• 22:34 How can we build community when we are physically or geographically isolated?
• 28:05 Have early retirements created a new dynamic in the workforce?
• 31:00 How can pediatricians keep a positive frame of mind when having difficult conversations around issues like science-denial and vaccine hesitancy?
• 39:16 How can adults model positivity and hope for the generation of children we are working with?
• 46:53 What can we do for our teams and communities to support both ourselves and others?
• 56:08 What advice do you have for maintaining resilience through the next several months?
 
Supporting the Emotional and Behavioral Health of Children, Adolescents, and Families during the COVID-19 Pandemic
November 5, 2020
View
Experts:
Elizabeth Alderman, MD, FAAP
Chair, Committee on Adolescence; Chief, Division of Adolescent Medicine at the Children’s Hospital at Montefiore and founder of the Montefiore Adolescent Primary Care Initiative.
Sherri L. Alderman, MD, MPH, IMHM-E®, FAAP
Chair, AAP Council on Early Childhood; Early Childhood Champion in Oregon, CDC Act Early Ambassador to Oregon.
Evelyn Berger-Jenkins, MD, MPH, FAAP
Member, AAP Committee on Psychosocial Aspects of Child and Family Health;  Assistant Professor of Child & Adolescent Health Columbia University Medical Center.
Carol  Weitzman, MD, FAAP
Co-Director Autism Spectrum Center, Division of Developmental Medicine at Boston Children's Hospital; Professor of Pediatrics at Yale
Timestamps:
• 3:35 Review of current pediatric COVID-19 case data
• 8:00 How do you start the conversation with families about their social-emotional health?
• 10:34 What is the importance of asking about social-emotional health for the families of infants?
• 12:09 How do you start a conversation with an adolescent about their social-emotional health?
• 14:20 What additional screening and surveillance is necessary at this time, especially for children who may be at high risk?
• 19:02 How does additional screen time impact social-emotional health and brain development?
• 21:05 What are the impacts of physical distancing and increased screen time on the social development of younger kids and infants?
• 23:36 What are some innovations to support children with developmental delays during this time?
• 28:56 There seems to be an increase in children with symptoms of anxiety and depression; is this because of the pandemic or because we have created an environment where more people are talking about mental health?
• 32:04 How do we determine which patients are struggling but have adequate support and coping skills and those who are struggling and may need referral for additional support?
• 36:45 Have your patterns of referral and partnership changed at all?
• 39:05 What ways can we help families cope with anxieties? 
• 48:30 How can we identify and address the ways disparities are affecting emotional development?
• 52:08 Has postpartum depression increased during the pandemic and how might the stress of the pandemic affect developing brains? 
• 53:45 How do we care for ourselves while supporting our patients and families through this challenging time?
 
COVID-19 Town Hall Session: COVID-19 and Kids – What’s the Latest?
October 22, 2020
View
Join us for our next COVID-19 Town Hall session on Thursday, October 22, 2020 at 7:00 pm CT. Get answers to your burning questions about COVID-19 in kids from AAP members with infectious disease, public health, and primary care expertise. Participants are encouraged to submit questions when they register, as well as during the live event.
Experts:
Kathy Anderson, MD, FAAP
President, AAP North Dakota Chapter, AAP District VI Diversity and Inclusion Champion, primary care pediatrician
Stephanie Griese, MD, MPH, FAAP
Member, AAP Council on Children and Disasters Executive Committee and Former Lead, CDC Children’s Preparedness Unit
Ruth Lynfield, MD, FAAP
Member, AAP Committee on Infectious Diseases, AAP Red Book Associate Editor, and State Epidemiologist and Medical Director at the Minnesota Department of Health
Bonnie Maldonado, MD, FAAP
Chairperson, AAP Committee on Infectious Diseases and Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development and Diversity at Stanford University School of Medicine
Timestamps:
• 7:30 What have we learned about COVID-19 and children since the beginning of the pandemic that all pediatricians should know about today?
• 13:40 How can pediatricians promote the use of cloth face coverings in our states and communities?
• 16:52 How can pediatricians support each other in these challenging times, especially as we approach the winter months?
• 18:41 What is the revised CDC guidance defining “close contacts” for COVID-19 released yesterday, and what does it mean for defining exposures?
• 25:03 What factors determine cumulative exposure and how does cumulative exposure impact quarantine recommendations and testing guidance?
• 28:39 As we enter influenza season, what are the recommendations for testing for COVID-19 and flu?
• 31:24 What are the recommendations for safe social activities and holiday gatherings?
• 33:55 How do you support breastfeeding during this time?
• 35:14 When should classrooms be quarantined and when should schools revert to hybrid or distance learning?
• 43:49 What is the current thinking about asymptomatic transmission, aerosolization, and fomites?
• 48:36 What PPE should pediatricians be using for well-child visits?
• 53:47 What can pediatricians do to address health disparities during the pandemic and beyond?
• 56:22 How do we continue to support each other and children in the months ahead?
 
Connecting with the Experts on Return to School and Sports
October 8, 2020
View
This session will focus on returning to school and sports. Join our experts to better understand the nuances and latest information about this evolving topic. During this event, participants are encouraged to ask their questions to prepare for a variety of scenarios during the pandemic.
Experts:
Susannah “Suz” Briskin, MD, FAAP
Executive Committee Member, AAP Council on Sports Medicine and Fitness and Associate Professor of Pediatrics in the Division of Sports Medicine at Rainbow Babies and Children’s Hospital; Head Team Physician for Hathaway Brown School and Assistant Team Physician for Case Western Reserve University.
Bonnie Maldonado, MD, FAAP
Chairperson, AAP Committee on Infectious Diseases and Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development and Diversity at Stanford University School of Medicine.
Sonja O’Leary, MD, FAAP
Chairperson-elect, AAP Council on School Health; Assistant Professor, Pediatrics University of Colorado School of Medicine; Medical Director, Denver Health, School-Based Health Centers. She currently leads 18 school-based health centers that provide comprehensive medical, mental and behavioral health, health education and dental services.
Christopher Snyder, MD, FAAP
Chairperson. AAP Section of Cardiology and Cardiac Surgery and Associate Professor, CWRU School of Medicine; Division Chief, Pediatric Cardiology,  UH Cleveland Medical Center and UH Rainbow Babies and Children's Hospital.
Timestamps:
• 4:10 Overview of COVID-19 in Children data
• 12:20 What degree of community spread is concerning and should impact return to school recommendations?
• 15:36 When should children (or a group of children such as a class or sports team) be quarantined or tested for COVID after a potential exposure in school or sports?
• 22:45 If someone has been exposed to COVID and is quarantined, should they be exercising?
• 24:15 AAP guidance on return to sports differs from the American College of Cardiology. What are some of the concerns about COVID, children, and sports?
• 26:28 What advice can be given to schools or communities to help them differentiate between “cold” symptoms and COIVD?
• 29:31 What type of COVID testing is recommended?
• 31:41 What are the mask recommendations for athletes? What other protective measures do you recommend?
• 34:34 How are you explaining to athletes how to celebrate their successes safely when they should not hug or high-five?
• 37:16 How are schools protecting staff and how should we think about PPE, particularly for children with special healthcare needs?
• 41:54 What is the current understanding of the aerosolization of COVID?
• 44:56 Are there additional considerations for children with special healthcare needs returning to sports?
• 47:45 What are the symptoms of myocarditis that I should be watching for in my primary care clinic? When should I get an EKG?
• 50:32 What about children and families that are not reporting their symptoms so they can continue to participate in sports and go to school?
• 53:24 Should children coming home from college quarantine?

• 55:34 How do you advise families to balance the risks of illness with the mental and physical benefits of going to school and participating in sports?
 
Connecting with the Experts on SARS-CoV-2 Testing
September 24, 2020 
View
This session focused on SARS-CoV-2 Testing.
Experts:
Bonnie Maldonado, MD, FAAP
Chairperson, AAP Committee on Infectious Diseases and Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development and Diversity at Stanford University School of Medicine.

Mark Cicero, MD, FAAP
Associate Professor, Pediatric Emergency Medicine at the Yale School of Medicine; Director, Pediatric Disaster Preparedness Program, and an Attending Physician at Yale-New Haven Children's Hospital; Chair, Pediatrics Committee of the National Association of EMS Physicians; Member of the National Biodefense Science Board.
Melissa Stockwell, MD MPH, FAAP 
Associate Director, AAP Pediatric Research in Office Settings (PROS) practice-based research network; Chief, Division of Child and Adolescent Health and an Associate Professor of Pediatrics and Population and Family Health at Columbia University Medical Center; Practices pediatrics in an academic-affiliated community health center; PI for two large CDC community cohort surveillance studies for COVID-19. 
Timestamps:
• 11:19 What are the differences between the PCR, antigen, and antibody tests?
• 15:10 What type of testing are you using in your practice setting and how did you decide which type to use?
• 18:34 When should we be considering antigen testing and why can’t I get antigen testing for my practice?
• 22:56 How are you working with public health and how has that relationship evolved?
• 25:20 What protocols have you implemented around the timing of testing for both symptomatic and asymptomatic patients?
• 31:35 Should we be testing all children with URI symptoms for COVID? When do we start testing for other diseases like influenza?
• 35:02 Are there certain children that you would want to make sure to test for coinfection or that you would test sooner in their illness?
• 38:43 If you have an asymptomatic child who is awaiting COVID test results, which of the child’s contacts need to stay home, and for how long?
• 41:40 Are you recommending reflex PCR testing in follow-up and are those tests covered by insurance?
• 47:00 What is the role of surveillance testing?
• 54:04 Are you recommending nasal or nasopharyngeal testing? What about testing from other sources like saliva or stool?
 
Caring for Patients with Acute Illness in Ambulatory Settings During the Pandemic
September 9, 2020
View
The first session addressed the AAP interim guidance for caring for patients with acute illness in ambulatory settings.
Experts: 
Susan Kressly, MD, FAAP, Steve Caddle, MD, FAAP and H. Dele Davies, MD, MS, MHCM, FAAP
Timestamps:
• 13:25 What is the best approach to screening patients with fever? Do all children with cold symptoms such as cough and congestion, with or without fever, need COVID/flu/strep testing?
• 17:03 How do you implement COVID triage in practice? 17:03
• 21:49 What is the guidance for returning to school or discontinuing isolation with a negative COVID test and COVID-like symptoms?
• 24:30 Does the timing of the initial COVID PCR test matter?
• 26:20 What is the accuracy of molecular testing versus antigen testing and when are symptoms considered resolved?
• 28:45 What are the recommendations when school protocols require a negative COVID test for a student to return?
• 34:44 How do you know that a patient presenting with rhinorrhea does not have COVID and this is the first presenting symptom?
• 36:02 How do you respond when a symptomatic patient with a known COVID exposure presents as a walk-in to your clinic?
• 41:22 How do you use your available PPE effectively?
• 44:30 Where or how do you see sick patients and deliver the right care to the right patient at the right time?
• 46:05 How do you clean a room after seeing a patient with a high probability of having COVID? What is your practice flow?
• 49:46 What do you recommend for the siblings of children who have been evaluated for COVID?
• 52:34 When should you send a child to a higher level of care outside of their medical home?